4
Changes in Ownership
NRX Pharmaceuticals, Inc. Filed Acc 0001415889-25-024084
Options or other derivatives
- Chairman and Chief Scientist acquired 125,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Javitt Jonathan C Chairman and Chief Scientist | 2025-04-09 | Grant or award · Stock Option (right to buy) | +125,000 | 125,000 | D | ||
Loading xslF345X05/form4-09102025_070903.xml…